Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Republic Bancorp A | RBCAA | Jan 17, 2025 | 68.43 | +1.39 |
Republic Services | RSG | Jan 17, 2025 | 213.73 | +0.85 |
Research Frontiers | REFR | Jan 17, 2025 | 1.66 | -0.59 |
Research Solutions | RSSS | Jan 17, 2025 | 3.65 | -5.44 |
Reservoir Media | RSVR | Jan 17, 2025 | 7.91 | +3.53 |
ReShape Lifesciences | RSLS | Jan 17, 2025 | 4.52 | -3.21 |
Resideo Technologies | REZI | Jan 17, 2025 | 22.96 | -0.26 |
ResMed | RMD | Jan 17, 2025 | 239.78 | +1.12 |
Resources Connection | RGP | Jan 17, 2025 | 8.50 | -0.70 |
Restaurant Brands International | QSR | Jan 17, 2025 | 60.48 | +0.02 |
Retail Bull 3X Direxion | RETL | Jan 17, 2025 | 9.40 | +0.64 |
Retail ETF Market Vectors | RTH | Jan 17, 2025 | 230.91 | +1.53 |
Retail Opportunity Investments | ROIC | Jan 17, 2025 | 17.45 | +0.35 |
ReTo Eco-Solutions | RETO | Jan 17, 2025 | 0.91 | +2.93 |
Retractable Technologies | RVP | Jan 17, 2025 | 0.79 | +0.50 |
REV Group | REVG | Jan 17, 2025 | 34.45 | +1.47 |
Revance Therapeutics | RVNC | Jan 17, 2025 | 3.68 | +12.54 |
Revelation Biosciences | REVB | Jan 17, 2025 | 0.40 | -3.45 |
Revelyst | GEAR | Jan 17, 2025 | 20.08 | 0.00 |
Revenueshares Largecap | RWL | Jan 17, 2025 | 101.62 | +0.89 |
Revenueshares Midcap | RWK | Jan 17, 2025 | 121.33 | +0.50 |
Revenueshares Smallcap | RWJ | Jan 17, 2025 | 46.97 | +0.56 |
Revenueshares Ultra Dividend Fund | RDIV | Jan 17, 2025 | 49.04 | +0.53 |
Reviva Pharmaceuticals | RVPH | Jan 17, 2025 | 1.77 | -0.56 |
Revolution Medicines | RVMD | Jan 17, 2025 | 40.29 | +0.98 |
Revolve Group A | RVLV | Jan 17, 2025 | 30.02 | +1.42 |
Revvity | RVTY | Jan 17, 2025 | 118.39 | -0.95 |
REX American Resources | REX | Jan 17, 2025 | 41.74 | -0.41 |
Rexford Industrial Realty | REXR | Jan 17, 2025 | 39.00 | -1.86 |
Rexford Industrial Realty B Pref | REXR-B | Jan 17, 2025 | 22.75 | -0.48 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.